Skip to main content

011: The 8.5 Fixes That Will Save Biomedical Science (R)

Josh and Daniel are on the road this week, so we decided to bring you some goodies from the archive.  An 8-ish step plan to save science!  

Biomedical science is broken.  Funding is unpredictable, training programs drag on indefinitely, and some of our best scientists are drawn to careers outside of the university or drowned in paperwork if they stay.  Can anything be done to support research staff and boost lab productivity?

Read More

090: Maybe Grant Funding Feels Random and Subjective Because It Is

Have you ever submitted a grant, only to have it rejected?  You respond to the reviewers’ comments, addressing weaknesses and tweaking the protocol to honor their suggestions.

Then, when you resubmit, the proposal is rejected again.  This new group of reviewers suggest changes to the protocol. And guess what, their suggestions sound a lot like your original idea that you removed to satisfy the last group of reviewers.

Are you the butt of some cruel academic joke, or is the grant funding process really this subjective and unpredictable?

Read More

income inequality

074: Does Science Have an Income Inequality Problem?

On May 2nd, NIH Director Francis Collins announced a plan to limit the total amount of grant funding awarded to an individual investigator or lab.

According to Collins, “the distribution of NIH grant funding is highly skewed, with 10 percent of NIH-funded investigators receiving over 40 percent of NIH funding.”

The funding proposal would limit an individual lab to the equivalent of 3 RO1-sized grants, and free up an additional 1600 funding opportunities that could go to early and mid-career scientists.

On June 8th, the plan was scrapped…

Addressing the 90%

This week on the show, we cover the contentious and somewhat confusing reversal of Collins’ plan to spur innovation by spreading around the money.

Did the plan change due to criticism from the labs with the deepest pockets? Or was there evidence to support the replacement plan that earmarks money for early-career scientists?

At the heart of this issue, we discuss whether basic research would benefit from a shift in investment strategy.

Do science and innovation advance faster when the ‘best’ labs get all the money, or is there value in making many smaller bets?

Tell us what YOU think in the comments below.

Everybeer

Some beers sing with complex aromas, malty bitterness, and just-right effervescence.  And then there’s brown ales.

This week, we sampled the Legend Brown Ale from Legend Brewing in Richmond, VA.  Don’t get me wrong, it’s a great beer.  Very tasty.  It just tastes like every other brown ale ever.  If you sneakily replaced the contents of this bottle with some other brown ale, I promise no one would notice.

I don’t know whether that makes us beer snobs or beer newbies.  Either way, we’re just counting down the days before we get back on our IPA kick…